Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T‐cell lymphoblastic lymphoma-Reference-Cited by-同舟云学术

Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T‐cell lymphoblastic lymphoma

Published:2022-08-24 Issue:11 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Salmerón‐Villalobos Julia¹²^ORCID,Ramis‐Zaldivar Joan Enric¹²^ORCID,Balagué Olga¹²³^ORCID,Verdú‐Amorós Jaime⁴^ORCID,Celis Verónica⁵,Sábado Constantino⁶^ORCID,Garrido Marta⁷,Mato Sara¹²^ORCID,Uriz Javier⁸,Ortega M. José⁹,Gutierrez‐Camino Angela¹⁰^ORCID,Sinnett Daniel¹⁰¹¹^ORCID,Illarregi Unai¹²^ORCID,Carron Máxime¹⁰^ORCID,Regueiro Alexandra¹³^ORCID,Galera Ana¹⁴^ORCID,Gonzalez‐Farré Blanca¹²³^ORCID,Campo Elias¹²³^ORCID,Garcia Noelia¹,Colomer Dolors¹²³^ORCID,Astigarraga Itziar¹⁵¹⁶^ORCID,Andrés Mara¹⁷^ORCID,Llavador Margarita¹⁸,Martin‐Guerrero Idoia¹⁹^ORCID,Salaverria Itziar¹²^ORCID

Affiliation:

1. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain

2. Centro de Investigación Biomédica en Red‐Oncología (CIBERONC) Madrid Spain

3. Haematopathology Unit Hospital Clínic Barcelona Spain

4. Paediatric Oncology Department Hospital Clínic Valencia Spain

5. Paediatric Oncology Department Hospital Sant Joan de Déu Esplugues de Llobregat Spain

6. Paediatric Oncology Department Hospital Vall d'Hebron Barcelona Spain

7. Anatomic Pathology Department Hospital Vall d'Hebron Barcelona Spain

8. Paediatric Oncohaematology Department Donostia University Hospital Biodonostia Health Research Institute San Sebastian Spain

9. Paediatric Oncology Department Hospital Universitario Virgen de la Nieves Granada Spain

10. Division of Haematology‐Oncology CHU Sainte‐Justine Research Center Montreal Canada

11. Department of Paediatrics Faculty of Medicine University of Montreal Montreal Canada

12. Genetics, Physics Anthropology and Animal Physiology Faculty of Science and Technology UPV/EHU Leioa Spain

13. Paediatric Haematology and Oncology Department Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela Spain

14. Paediatric Oncohaematology Department Hospital Clínico Universitario Virgen de la Arrixaca Murcia Spain

15. Paediatric Department Osakidetza Biocruces Bizkaia Health Research Institute Hospital Universitario Cruces Barakaldo Spain

16. Paediatric Department Universidad del Pais Vasco UPV/EHU Leioa Spain

17. Paediatric Oncology Department Hospital La Fe Valencia Spain

18. Anatomic Pathology Department Hospital La Fe Valencia Spain

19. Biocruces Bizkaia Health Research Institute Department of Genetics, Physical Anthropology & Animal Physiology, Science and Technology Faculty University of the Basque Country UPV/EHU Leioa Spain

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29926

Reference74 articles.

1. SEER*Explorer: an interactive website for SEER cancer statistics [Internet]. Surveillance Research Program.National Cancer Institute. Accessed September 27 2021.https://seer.cancer.gov/explorer/

2. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence

3. T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?

4. T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses

5. High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NOTCH1 fusions in pediatric T‐cell lymphoblastic lymphoma: A high‐risk subgroup with CCL17 (TARC) levels as diagnostic biomarker;HemaSphere;2024-06-27

2. NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: a high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker;2024-02-02

3. Decoding the genetic symphony: Profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights;PNAS Nexus;2024-01-12

4. Challenging our understanding of B‐cell lymphomagenesis and risk: Paediatric high‐grade B‐cell lymphoma, not otherwise specified with a DDX3X::MLLT10 fusion and an IGH deletion;Pediatric Blood & Cancer;2023-12-16

5. Investigating the physiological role of S199A and S199D mutants of PHF6 protein in T-cell acute lymphoblastic leukemia;Turkish Journal of Medical Sciences;2023-10-26